← Evidence map

ReviewDrugs2020

Risankizumab: A Review in Moderate to Severe Plaque Psoriasis.

Hannah A BlairPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

22 papers cite it

2020
2021
2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32632826